However, long-standing concerns exist regarding a potential association between GH treatment and the development or recurrence of neoplasms (4–8) and the effect on glucose homeostasis, including development of type 2 diabetes mellitus (T2DM) (9). The gene discussed is GH1; the disease is diabetes mellitus.